We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HPQ:NYSEHP Inc. Analysis

Data as of 2026-03-11 - not real-time

$18.79

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

HP Inc. trades at $18.79, below its 20‑day (18.87) and 50‑day (19.89) SMAs, signaling a short‑term bearish bias, yet the MACD histogram is positive and volume is rising, hinting at a possible near‑term bounce. The stock offers a 6.39% dividend yield with a 44% payout ratio and generates solid free cash flow, but carries a high debt load and a negative book value, raising balance‑sheet concerns. Valuation metrics are extremely attractive – a trailing P/E of 7.1 versus an industry average of 36.8 and a DCF fair value near $49 – suggesting the market may be undervaluing the business. Recent earnings have beaten expectations, but analyst sentiment is mixed, with Morgan Stanley cutting its target to $16 and rating the stock underweight, while other commentary highlights HP as an undervalued AI play.
Overall, the combination of cheap valuation, strong dividend, and modest revenue growth supports a longer‑term case, but the current technical weakness and elevated volatility (~35% 30‑day) warrant caution in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below 20‑day and 50‑day SMAs indicating bearish momentum
  • Positive MACD histogram and rising volume suggest a possible short‑term rebound
  • High 30‑day volatility and mixed analyst sentiment increase uncertainty

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation discount versus industry peers (P/E ~7 vs 37)
  • Attractive 6.39% dividend yield with a comfortable payout ratio
  • Steady revenue growth (~7%) and positive free cash flow supporting earnings stability

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑run upside potential reflected by DCF fair value (~$49) far above current price
  • Strategic positioning in AI‑enabled printing and hybrid work solutions
  • Dividend compounding and mean‑reversion expectations as market re‑prices the stock

Key Metrics & Analysis

Financial Health

Revenue Growth6.90%
Profit Margin4.46%
P/E Ratio7.1
ROA5.62%
P/B Ratio-22.5
Op. Cash Flow$3.7B
Free Cash Flow$2.8B
Industry P/E36.8

Technical Analysis

TrendBearish
RSI44.1
Support$17.56
Resistance$20.42
MA 20$18.87
MA 50$19.89
MA 200$24.48
MACDBullish
VolumeIncreasing
Fear & Greed Index76.91

Valuation

Fair Value$49.00
Target Price$19.99
Upside/Downside6.41%
GradeUndervalued
TypeValue
Dividend Yield6.39%

Risk Assessment

Beta1.25
Volatility35.07%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.